| __timestamp | ADMA Biologics, Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 246000000 |
| Thursday, January 1, 2015 | 7015946 | 582800000 |
| Friday, January 1, 2016 | 7688238 | 455000000 |
| Sunday, January 1, 2017 | 6229587 | 366000000 |
| Monday, January 1, 2018 | 3926120 | 414000000 |
| Tuesday, January 1, 2019 | 2343848 | 471000000 |
| Wednesday, January 1, 2020 | 5907013 | 452000000 |
| Friday, January 1, 2021 | 3646060 | 465000000 |
| Saturday, January 1, 2022 | 3613764 | 529000000 |
| Sunday, January 1, 2023 | 3300000 | 604000000 |
Infusing magic into the data realm
In the ever-evolving landscape of biotechnology and pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, ADMA Biologics, Inc. and Bausch Health Companies Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Bausch Health consistently allocated a significant portion of its resources to R&D, with expenditures peaking at approximately $604 million in 2023, marking a 146% increase from 2014. In contrast, ADMA Biologics' R&D spending showed a downward trend, decreasing by about 65% over the same period, from $9.5 million in 2014 to $3.3 million in 2023. This divergence highlights Bausch Health's robust focus on innovation, while ADMA Biologics appears to be more conservative in its R&D investments. As the industry continues to advance, these strategic choices will likely shape the future trajectories of both companies.
Comparing Innovation Spending: Eli Lilly and Company and ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Bausch Health Companies Inc.
Neurocrine Biosciences, Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
R&D Insights: How Summit Therapeutics Inc. and ADMA Biologics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and ADMA Biologics, Inc.
Research and Development: Comparing Key Metrics for Grifols, S.A. and Bausch Health Companies Inc.
Axsome Therapeutics, Inc. or ADMA Biologics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and PTC Therapeutics, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How ADMA Biologics, Inc. and MiMedx Group, Inc. Allocate Funds